Post-Transplant Recurrence of Neuroendocrine Tumors Abstract #2792

Introduction: Recurrence after liver transplantation (LT) for metastases from NET is observed in 30-50% of cases at 5 years after LT but management is individualized
Aim(s): Aim of this study is to identify factors influencing post-recurrence survival and to define the best treatment according to disease presentation
Materials and methods: Consecutive patients treated at a single Institution for post-LT recurrence of NET were included. Baseline patients’ characteristics, primary tumor data, pre-transplant therapies, post-transplant recurrence and long term outcomes were collected and analyzed
Conference: 17th Annual ENETS Conference 2020 (2020)
Category: Surgical treatment and Ablative Therapies
Presenting Author: MD Michela Monteleone

To read results and conclusion, please login ...

Further abstracts you may be interested in

#530 Liver Transplantation for Metastatic Neuroendocrine Tumor: A Case Series and Proposed Selection Criteria
Introduction: Liver transplantation (LT) for neuroendocrine tumor (NET) metastases is associated with a high risk of tumor recurrence. Patient selection is the key to future success and its increased utilization.
Conference: 9th Annual ENETS Conference (2012)
Category: Clinical
Presenting Author: Dr. Douglas Quan
Authors: Chan G, Kocha W, Reid R, Taqi A, ...
#1552 Liver Transplantation for Gastroenteropancreatic Neuroendocrine Tumors
Introduction: Neuroendocrine tumors (NET) are rare neoplasms and liver transplantation (LT) for hepatic metastases is indicated in selected cases where other therapies have failed.
Conference: 13th Annual ENETS conference 2016 (2016)
Category: Surgical treatment
Presenting Author: PhD Estela Regina Ramos Figueira
#2225 Long Term Survival after Transplant for Neuroendocrine Liver Metastases: A Case Report and Literature Review
Introduction: Liver transplantation (LT) is offered to selected patients of neuroendocrine tumours (NETs) with unresectable liver metastases (NELM).
Conference: 15th Annual ENETS conference 2018 (2018)
Category: Case reports
Presenting Author: Prasad Pande
Authors: Pande P, Desai G, Shah R, Palepu J, ...
#2295 Results of Liver Transplantation in Patients with Neuroendocrine Tumors
Introduction: liver transplantation (LTx) for patients with neuroendocrine tumors (NET) is a option for patients con metastasis limited to the liver.
The main indication is when the metastatic NET of the liver not accessible to surgery or reduction.
Conference: 15th Annual ENETS conference 2018 (2018)
Category: Case reports
Presenting Author: Physicians Juan Carlos Percovich
#2700 Pancreatic Neuroendocrine Neoplasms and Liver Metastases: When Size Matters
Introduction: Small non-functioning pNENs are low grade indolent tumors, however distant metastases have also been documented in this subset of patients
Conference: 17th Annual ENETS Conference 2020 (2020)
Category: Surgical treatment and Ablative Therapies
Presenting Author: MD Michela Monteleone